DelveInsight’s c-MET-NSCLC pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline ...

Nurix Therapeutics (NRIX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeet ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $30.00.

Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation ...

These SCFAs can influence the activity of both cancer-promoting (proto-oncogenes) and cancer-suppressing (tumor-suppressor) genes by modifying histones, the proteins that help package DNA.

An oncogene is a gene that will transform a cell in culture. Oncogenes were initially identified in cancer-causing retroviruses. Genes involved in the regulation of cell division, movement and ...

Department of Nephrology, Henan Key Laboratory of Kidney Disease and Immunology, Henan Provincial People’s Hospital, Zhengzhou, Henan, China Parathyroid hormone (PTH) is a pivotal hormone that ...

Oncogenes are genes that can cause cancer, which can happen through mutation of DNA. Your body’s DNA contains instructions for making proteins. When the DNA is damaged, it can’t always make proteins ...

Geologist Juan Manuel García Ruiz still speaks with amazement about how he and his colleagues have created “a proto-world” in their laboratory, located just 1,500 meters from La Concha beach in the ...

For example, there’s something called oncogenes, which are genes that turn on [mutate] and can cause cancer, and there are tumour suppressor genes, which when turned on help to suppress cancer.